Adding L-Carnitine and Selenium to Methimazole in Graves' Disease: A Prospective Randomized Trial on Thyroid Markers and Quality of Life.
- 2025-08-20
- RCT · n = 60
- Nutrients 17(16)
- Mattia Rossi
- Letizia Meomartino
- Marco Zavattaro
- Gloria Selvatico
- Ruth Rossetto Giaccherino
- Loredana Pagano
- PubMed: 40871722
- DOI: 10.3390/nu17162693
- High evidence
- Rigorous Journal
- Clinical
MMI requirements were consistently lower in the Intervention Group, both in average dosage (p = 0.013) and cumulative dose (p = 0.020)
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- not stated